Categories
Search
Collections
Express Licenses
Sign In

Cell therapy methods for improved transplant acceptance

Overview
Request Info
More Like This
Express Licensing
Search text
About 24 results
(0.12 seconds)
Treatment and prevention of intestinal graft-versus-host disease following HPSC transplantation
CU19098
This technology is a method of bolstering immune defenses in intestinal tissue for the prevention and treatment of graft-versus-host disease, which is often caused by allogeneic hematopoietic stem cell transplantation.
Prevention and treatment of GVHD following HPSC transplantation.
Allogeneic hematopoietic stem cell (HPSC) transplantation, a common therapy for various genetic diseases and cancers, often results in potentially fatal complications, such as graft-versus-host disease (GVHD).
12AllotransplantationAutoimmune diseaseChemotherapy
Ran Reshef
Jerry Kokoshka
Oncology
Columbia University Medical Center (CUMC)
2020-12-10
Conversion and condition-resistant regulatory T-cells for immunosuppressive therapy and tissue repair
CU22040
Treatment to reduce and/or prevent organ transplant rejection or complications of transplant.
This approach can be used to treat, reduce, or prevent transplant rejection, autoimmune diseases, and graft-versus-host disease by promoting systemic immune tolerance or immunosuppression.
This approach can be used to treat, reduce, or prevent transplant rejection, autoimmune diseases, and graft-versus-host disease by promoting systemic immune tolerance or immunosuppression.
15Autoimmune diseaseChimeric antigen receptor T cellDrug delivery
Megan Sykes M.D.Mohsen Khosravi MaharlooeiRemi Creusot
Jerry Kokoshka
Medicine
Columbia University Medical Center (CUMC)
2023-01-30
Targeted pharmacological agents for the prevention of multiple organ failure in hemorrhagic shock patients
CU23263
Preventative medicine for multiple organ failure.
Direct prevention and treatment of shock-induced multiple organ failure.
This technology is a pharmacological intervention targeting localized inflammatory responses in trauma and hemorrhagic shock to prevent multiple organ failure.
16AdenosineAdenosine receptorAgent-based model
George HaskoTaha Kelestemur
Kristin Neuman
Anesthesiology
Columbia University Medical Center (CUMC)
2024-04-25
    • Tags
      • 16
        T cell
      • 12
        Immunotherapy
      • 10
        Neoplasm
      • 8
        Cytotoxic T cell
      • 7
        Transplant rejection
      • Add ...
    • Categories
      • 24
        Biology
      • 24
        Branches of biology
      • 19
        Anatomy
      • 22
        Biological systems
      • 22
        Organ systems
      • Add ...
    • Inventors
      • 3
        Hong Jiang
      • 3
        John Loike
      • 3
        Leonard Chess MD
      • 3
        Raphael Clynes MD, PhD
      • 3
        Sadna Budhu
      • Add ...
    • Manager
      • 6
        Jerry Kokoshka
      • 6
        Joan Martinez
      • 6
        Sara Gusik
      • 2
        Cynthia Lang
      • 2
        Dovina Qu
      • Add ...
    • Departments
      • 16
        Medicine
      • 4
        Biomedical Engineering
      • 4
        Biomedical Informatics
      • 3
        Physiology
      • 3
        Physiology and Cellular Biophysics
      • Add ...
    • Divisions
      • 21
        Columbia University Medical Center (CUMC)
      • 4
        Fu Foundation School of Engineering and Applied Science (SEAS)
      • 1
        Catalan Institution for Research and Advanced Studies (ICREA)
      • 1
        College of Physicians and Surgeons (CUMC)
      • 1
        Hematology
      • Add ...
    • Reference Number
      • Add ...
    • Release Date
This site uses cookies to deliver a better user experience. Learn more.